Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials.
antineoplastic agents
drug repositioning
etodolac
imatinib
leuprolide
mebendazole
medical oncology
metformin
multimorbidity
propranolol
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 May 2023
30 May 2023
Historique:
received:
25
02
2023
revised:
19
05
2023
accepted:
27
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Quality pharmacological treatment can improve survival in many types of cancer. Drug repurposing offers advantages in comparison with traditional drug development procedures, reducing time and risk. This systematic review identified the most recent randomized controlled clinical trials that focus on drug repurposing in oncology. We found that only a few clinical trials were placebo-controlled or standard-of-care-alone-controlled. Metformin has been studied for potential use in various types of cancer, including prostate, lung, and pancreatic cancer. Other studies assessed the possible use of the antiparasitic agent mebendazole in colorectal cancer and of propranolol in multiple myeloma or, when combined with etodolac, in breast cancer. We were able to identify trials that study the potential use of known antineoplastics in other non-oncological conditions, such as imatinib for severe coronavirus disease in 2019 or a study protocol aiming to assess the possible repurposing of leuprolide for Alzheimer's disease. Major limitations of these clinical trials were the small sample size, the high clinical heterogeneity of the participants regarding the stage of the neoplastic disease, and the lack of accounting for multimorbidity and other baseline clinical characteristics. Drug repurposing possibilities in oncology must be carefully examined with well-designed trials, considering factors that could influence prognosis.
Identifiants
pubmed: 37296934
pii: cancers15112972
doi: 10.3390/cancers15112972
pmc: PMC10251882
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Am J Hematol. 2021 Apr 1;96(4):E95-E98
pubmed: 33373063
Front Public Health. 2021 Sep 28;9:729559
pubmed: 34650951
Endocr Pract. 2011 May-Jun;17(3):e59-62
pubmed: 21454232
Diabetes Res Clin Pract. 2014 Oct;106(1):19-26
pubmed: 24837144
Invest New Drugs. 2017 Dec;35(6):813-819
pubmed: 28936567
Blood Adv. 2020 Feb 11;4(3):467-476
pubmed: 32027744
Nat Rev Drug Discov. 2004 Aug;3(8):673-83
pubmed: 15286734
Trends Endocrinol Metab. 2019 Oct;30(10):745-755
pubmed: 31405774
Prostate. 2013 Feb 15;73(3):250-60
pubmed: 22821802
Cancer Treat Res Commun. 2020;24:100192
pubmed: 32673846
Theranostics. 2018 Mar 28;8(9):2488-2495
pubmed: 29721094
Mol Cancer Ther. 2015 Jan;14(1):3-13
pubmed: 25376612
BMJ Open. 2020 Sep 30;10(9):e040406
pubmed: 32998931
Indian J Cancer. 2013 Jul-Sep;50(3):250-3
pubmed: 24061467
Cancer Sci. 2020 Mar;111(3):924-931
pubmed: 31943636
Gynecol Oncol. 2021 Jan;160(1):302-311
pubmed: 33131904
In Vitro Cell Dev Biol Anim. 2002 May;38(5):298-304
pubmed: 12418927
Int J Mol Sci. 2022 Feb 28;23(5):
pubmed: 35269852
Mol Cancer Ther. 2002 Nov;1(13):1201-9
pubmed: 12479701
Front Oncol. 2021 Apr 19;11:658636
pubmed: 33954114
Cancer Chemother Pharmacol. 2008 Apr;61(5):809-17
pubmed: 17581752
Leukemia. 2018 Apr;32(4):882-889
pubmed: 29089643
Cancer. 2020 Sep 1;126(17):3991-4001
pubmed: 32533792
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Lancet Respir Med. 2021 Sep;9(9):957-968
pubmed: 34147142
Trials. 2022 Jan 19;23(1):57
pubmed: 35045869
Pharmacol Res. 2017 Oct;124:74-91
pubmed: 28712971
F1000Res. 2018 Nov 15;7:1797
pubmed: 30647912
Ecancermedicalscience. 2014 Nov 26;8:485
pubmed: 25525463
Life Sci. 2022 Sep 1;304:120680
pubmed: 35662589
Acta Oncol. 2014 Mar;53(3):427-8
pubmed: 24160353
Cancer. 2016 Jan 15;122(2):324-5
pubmed: 26445397
Cancer Treat Res Commun. 2019;20:100150
pubmed: 31102920
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Contemp Clin Trials. 2021 Aug;107:106488
pubmed: 34166841
J Natl Cancer Inst. 1999 Jan 6;91(1):22-36
pubmed: 9890167
Nat Rev Drug Discov. 2003 Sep;2(9):695-702
pubmed: 12951576
Medicina (Kaunas). 2022 Sep 07;58(9):
pubmed: 36143915
Ann Otol Rhinol Laryngol. 2023 Mar;132(3):332-340
pubmed: 35466712
J Med Chem. 2012 Aug 9;55(15):6832-48
pubmed: 22780961
PLoS Med. 2016 Oct 11;13(10):e1002139
pubmed: 27727279
Urol Oncol. 2021 Dec;39(12):831.e1-831.e10
pubmed: 34167872
Radiother Oncol. 2016 Mar;118(3):453-9
pubmed: 26861738
J Neurooncol. 2016 Jun;128(2):259-66
pubmed: 26966095
Cancer Med. 2020 Jul;9(13):4676-4685
pubmed: 32400117
Nat Med. 1999 Dec;5(12):1418-23
pubmed: 10581086
BMJ. 2005 Jun 4;330(7503):1304-5
pubmed: 15849206
Cancer Epidemiol. 2012 Aug;36(4):e243-50
pubmed: 22417708
Cancer Res. 2001 Apr 1;61(7):2866-9
pubmed: 11306460
Am J Hematol. 2017 Jan;92(1):50-55
pubmed: 27733010
Br J Anaesth. 2019 Nov;123(5):554-559
pubmed: 31558313
Drug Discov Today. 2019 Apr;24(4):1059-1065
pubmed: 30878563
Nat Cancer. 2020 Feb;1(2):235-248
pubmed: 32613204
Oncotarget. 2017 Feb 21;8(8):12576-12595
pubmed: 28157711
Ann Surg Oncol. 2008 Jul;15(7):2042-52
pubmed: 18398660
Lancet. 1964 May 16;1(7342):1080-1
pubmed: 14132613
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):195-207
pubmed: 30196056
Onco Targets Ther. 2012;5:391-401
pubmed: 23226026
Plast Reconstr Surg. 2021 Apr 1;147(4):875-885
pubmed: 33776033
Oncotarget. 2016 Oct 18;7(42):68571-68584
pubmed: 27612418
J Clin Neurosci. 2022 Jan;95:48-54
pubmed: 34929651
Int J Mol Sci. 2023 Jan 10;24(2):
pubmed: 36674870
Diabetes Care. 2010 Jul;33(7):1674-85
pubmed: 20587728
J Clin Oncol. 2009 Jul 10;27(20):3297-302
pubmed: 19487376
Front Pharmacol. 2022 May 13;13:850750
pubmed: 35645803
Radiother Oncol. 2020 Oct;151:95-105
pubmed: 32592892
Oncologist. 2013;18(2):163-73
pubmed: 23340005
PLoS One. 2018 Jun 1;13(6):e0198389
pubmed: 29856824
JAMA. 1971 Jul 19;217(3):313-6
pubmed: 5109194
Immunopharmacol Immunotoxicol. 2017 Aug;39(4):199-210
pubmed: 28472897
Aging (Albany NY). 2021 Sep 16;13(18):21866-21902
pubmed: 34531332
Front Oncol. 2022 Jul 11;12:942380
pubmed: 35898873
ACS Omega. 2022 Dec 29;8(1):56-73
pubmed: 36643505
Metabolism. 2022 Aug;133:155223
pubmed: 35640743
J Cell Physiol. 2019 Apr;234(4):4191-4199
pubmed: 30362518
Clin Cancer Res. 2002 Sep;8(9):2963-9
pubmed: 12231542
Cancer. 2007 Sep 1;110(5):1149-61
pubmed: 17634948
Br J Cancer. 1999 Jan;79(1):119-30
pubmed: 10408703
Anticancer Drugs. 2013 Feb;24(2):181-8
pubmed: 23059386
Cancer. 2014 Apr 15;120(8):1178-86
pubmed: 24415516
Am J Respir Crit Care Med. 2015 Feb 15;191(4):448-54
pubmed: 25522257
Leuk Lymphoma. 2020 Jul;61(7):1669-1677
pubmed: 32268821
Haematologica. 2013 Nov;98(11):1663-6
pubmed: 24186311
Trials. 2021 Jul 5;22(1):428
pubmed: 34225765
Trials. 2020 Oct 28;21(1):897
pubmed: 33115543
Ann Oncol. 2016 Dec;27(12):2184-2195
pubmed: 27681864
Cochrane Database Syst Rev. 2018 Apr 18;4:CD006545
pubmed: 29667726
Neurooncol Adv. 2020 Nov 12;3(1):vdaa154
pubmed: 33506200
Oncologist. 2018 Jul;23(7):859-865
pubmed: 29487223
Lancet Oncol. 2015 Jul;16(7):839-47
pubmed: 26067687
EClinicalMedicine. 2022 May 27;49:101449
pubmed: 35747192
Br Med J. 1965 Aug 7;2(5457):337-9
pubmed: 14314452
BMJ Open. 2019 Dec 2;9(12):e033131
pubmed: 31796494
BMC Cancer. 2018 May 24;18(1):593
pubmed: 29793446
Neuro Oncol. 2011 Sep;13(9):974-82
pubmed: 21764822
Expert Rev Anticancer Ther. 2022 Apr;22(4):415-436
pubmed: 35259320
Cancer Res. 2006 Jul 15;66(14):7059-66
pubmed: 16849551
J Cancer Res Clin Oncol. 2013 Feb;139(2):327-35
pubmed: 23080133
Life Sci. 2022 Jun 15;299:120536
pubmed: 35385794
Life Sci. 2020 Oct 1;258:118189
pubmed: 32781060
Clin Cancer Res. 2017 Aug 15;23(16):4651-4661
pubmed: 28490464
Cancer Res. 1995 Aug 15;55(16):3504-8
pubmed: 7627955
Trials. 2022 Feb 16;23(1):158
pubmed: 35172891
Cell Adh Migr. 2020 Dec;14(1):118-128
pubmed: 32538273
Int J Oncol. 2015 Mar;46(3):1225-31
pubmed: 25530018
Cancers (Basel). 2019 Aug 31;11(9):
pubmed: 31480477
Thromb Res. 2007;120 Suppl 2:S107-11
pubmed: 18023703
Eur J Med Chem. 2022 Apr 15;234:114239
pubmed: 35290843
Nat Med. 2014 Aug;20(8):833-46
pubmed: 25100529
Neurosurgery. 2019 Dec 1;85(6):843-853
pubmed: 30476251
J Pathol. 2023 Jan;259(1):69-80
pubmed: 36245401